Bactiguard Holding AB Series B | Balance Sheet

Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
5,417.00
105,147.00
22,119.00
15,645.00
11,550.00
1,893
Total Accounts Receivable
96,349.00
86,642.00
56,254.00
30,667.00
41,642.00
57,716
Inventories
3,590.00
8,974.00
11,687.00
15,144.00
13,608.00
14,266
Other Current Assets
7,914.00
8,285.00
9,591.00
9,704.00
11,254.00
11,197
Total Current Assets
113,270.00
209,048.00
99,651.00
71,160.00
78,054.00
85,072
Net Property, Plant & Equipment
19,501.00
31,779.00
30,761.00
25,729.00
35,717.00
29,790
Total Investments and Advances
1,293.00
1,368.00
1,298.00
1,228.00
-
-
Long-Term Note Receivable
-
9,531.00
6,012.00
16,170.00
17,263.00
477
Intangible Assets
583,166.00
559,402.00
538,524.00
517,787.00
494,356.00
472,138
Other Assets
-
-
1.00
1.00
-
-
Total Assets
750,836.00
844,734.00
709,852.00
665,680.00
658,996.00
587,477
ST Debt & Current Portion LT Debt
57,461.00
-
142,140.00
100,000.00
7,500.00
Accounts Payable
7,397.00
10,995.00
4,017.00
4,896.00
4,832.00
Other Current Liabilities
39,521.00
46,617.00
77,879.00
38,358.00
28,471.00
Total Current Liabilities
104,379.00
57,612.00
224,036.00
143,254.00
40,803.00
Long-Term Debt
427,500.00
195,569.00
-
50,000.00
142,500.00
Deferred Taxes
44,398.00
39,237.00
34,767.00
30,285.00
25,243.00
Other Liabilities
-
-
-
18,207.00
29,739.00
Total Liabilities
609,883.00
326,024.00
292,409.00
275,352.00
271,891.00
Common Equity (Total)
140,953.00
518,710.00
417,443.00
390,328.00
387,105.00
Total Shareholders' Equity
140,953.00
518,710.00
417,443.00
390,328.00
387,105.00
Total Equity
140,953.00
518,710.00
417,443.00
390,328.00
387,105.00
Liabilities & Shareholders' Equity
750,836.00
844,734.00
709,852.00
665,680.00
658,996.00

About Bactiguard Holding AB

View Profile
Address
Alfred Nobels Allé 150
Tullinge AB 146 21
Sweden
Employees -
Website http://www.bactiguard.se
Updated 07/08/2019
Bactiguard Holding AB is a medical device company, which engages in developing and supply infection protection solutions. Its product portfolio includes foley catheter, central venous catheters, and endotracheal tubes. The company was founded on October 27, 2010 and is headquartered in Stockholm, Sweden.